randomized, open-label phase IIa trial
is a Phase I device trial planned to be conducted on 8 patients. First patient was implanted on the 13th of June 2019.
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of special 4 Weeks Treatment
The multicentric CIBIS–ELD trial compares two different pharmacological beta-blockers in elderly patients with chronic heart failure.
MOLITOR is a multicentric, multinational observational study of biomarkers in acute decompensated heart failure.
The study investigates why some patients with heart failure show poor results in clinical study outcome, despite conventional treatments.
Primary objective of ETiCS is to explore the reasons which lead to production of anti-beta1-antibodies in patients with acute myocarditis.
The main goal is to prove the monitoring ability of KYMA system, relevant in detection of cardiovascular changes in post discharge chronic heart failure patients.
Copyrights 2020 SciRent